2,4-二硝基苯酚(DNP)中毒的毒物流行病学及死亡预测因素
该研究提取2007-2018年英美两国中毒中心报告的204例全身性DNP暴露病例(美国86例,英国118例),分析其流行病学特征及与死亡相关的临床特征。结果显示英国报告发病率高于美国(1.78 vs 0.26例/百万人口),两国病死率均高且无显著差异(美国11.6%,95%CI 6.4-20.1%;英国16.9%,95%CI 11.3-24.7%;p=0.29)。多因素分析保留酸中毒(OR=5.4)、心动过速(OR=3.6)、躁动/意识模糊(OR=3.4)和高热(OR=2.8)为独立死亡预测因素。提示临床遇到DNP中毒患者出现上述表现时应迅速升级至ICU进行积极支持治疗和监测。
要点
- DNP中毒总体病死率高:美国11.6%(95%CI 6.4-20.1%),英国16.9%(95%CI 11.3-24.7%),两国间无显著差异(p=0.29)。
- 多因素分析显示酸中毒(OR=5.4,95%CI 1.8-16.5)、心动过速(OR=3.6,95%CI 1.2-11.0)、躁动/意识模糊(OR=3.4,95%CI 1.2-9.7)和高热(OR=2.8,95%CI 1.0-7.4)是死亡的独立预测因素。
- 单因素分析中与死亡显著相关的还包括低血糖(OR=17.1)、肌张力增高(OR=12.9)、乳酸升高(OR=8.3)、高血压(OR=5.6)和呼吸急促/呼吸困难(OR=2.8)。
- 出现心动过速、高热、酸中毒和躁动/意识模糊时应迅速升级至ICU环境进行积极支持治疗和监测。
- 2007-2018年间英美两国DNP中毒年报告病例数自2011年起均增加,英国报告发病率高于美国(1.78 vs 0.26例/百万人口)。
适用人群与场景
- 2007-2018年向美国与英国中毒中心报告的全身性DNP暴露病例,共204例(美国86例,英国118例);86%年龄低于40岁,71%为男性。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 出现心动过速、高热、酸中毒和躁动/意识模糊时应迅速升级至ICU环境进行积极支持治疗和监测。
红旗征与不能漏的情况
- 酸中毒(多因素OR=5.4,95%CI 1.8-16.5)、心动过速(OR=3.6,95%CI 1.2-11.0)、躁动/意识模糊(OR=3.4,95%CI 1.2-9.7)、高热(OR=2.8,95%CI 1.0-7.4)为独立死亡预测因素,出现时应迅速升级至ICU积极支持治疗和监测。
- 单因素分析中低血糖(OR=17.1)、肌张力增高(OR=12.9)、乳酸升高(OR=8.3)、高血压(OR=5.6)、呼吸急促/呼吸困难(OR=2.8)亦与死亡风险显著相关。
研究设计与关键结果
- 研究类型为中毒中心报告病例的回顾性分析,样本量204例(美国86例,英国118例),未提及中心数。
- 主要终点病死率:美国11.6%(95%CI 6.4-20.1%)vs 英国16.9%(95%CI 11.3-24.7%),两国间无显著差异(X2(1)=1.12,p=0.29)。
- 报告发病率:英国1.78例/百万人口 vs 美国0.26例/百万人口;两国年病例数自2011年起均增加。
- 多因素logistic回归保留的独立死亡预测因素:酸中毒OR=5.4(95%CI 1.8-16.5)、心动过速OR=3.6(95%CI 1.2-11.0)、躁动/意识模糊OR=3.4(95%CI 1.2-9.7)、高热OR=2.8(95%CI 1.0-7.4)。
- 单因素分析显著关联:低血糖OR=17.1(95%CI 1.7-174.3)、肌张力增高OR=12.9(95%CI 3.5-47.6)、酸中毒OR=12.5(95%CI 4.8-32.9)、乳酸升高OR=8.3(95%CI 2.4-28.4)、高热OR=6.5(95%CI 2.8-15.2)、心动过速OR=6.4(95%CI 2.5-16.4)、躁动/意识模糊OR=6.0(95%CI 2.6-13.7)、高血压OR=5.6(95%CI 1
证据类型、等级与局限
- 证据类型:基于中毒中心报告数据的回顾性分析(原文未明确标注证据等级)。
- 原文未述局限性。
对床旁实践的改变
- 急诊/ICU医生接诊DNP中毒患者时,应认识到其病死率高(美国11.6%,英国16.9%),出现酸中毒、心动过速、躁动/意识模糊或高热时应迅速升级至ICU进行积极支持治疗和监测。
- 单因素分析中低血糖、肌张力增高、乳酸升高、高血压和呼吸急促/呼吸困难也与死亡风险显著相关,提示需关注这些临床特征。
- 原文未提及适用与不适用人群的进一步区分或常见陷阱。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: 2,4-Dinitrophenol (DNP) is a highly toxic industrial chemical that is sometimes misused to reduce body fat. Toxicity following ingestion of DNP has recently become more common in the United Kingdom. This research was performed to document the frequency of DNP toxicity as reported to poisons centres in the United States (US) and United Kingdom (UK) and to identify the clinical features associated with fatality.
METHODS: Calls to UK and US poisons centres involving systemic exposure to DNP were extracted for the 12 calendar years 2007-2018. These were analysed using univariate and multivariate statistical techniques.
RESULTS: There were 204 cases (n = 86, US; n = 118, UK) of systemic DNP exposure identified, of which 86% were under the age of 40 and 71% were males. Over the study period the incidence of reported DNP toxicity was higher in the United Kingdom than the United States (1.78 vs. 0.26 cases per million population) and annual case numbers have increased in both countries since 2011. Case fatality was high and did not differ significantly between countries (US 11.6%; 95% CI: 6.4-20.1%: UK 16.9%; 95% CI: 11.3-24.7%; X2(1) = 1.12, p = 0.29). Univariate analysis demonstrated significant associations between risk of death and the presence of hypoglycaemia (OR = 17.1, 95% CI 1.7-174.3), hypertonia (OR = 12.9, 95% CI 3.5-47.6), acidosis (OR = 12.5, 95% CI 4.8-32.9), raised lactate (OR = 8.3, 95% CI 2.4-28.4), hyperpyrexia (OR = 6.5, 95% CI 2.8-15.2), tachycardia (OR = 6.4, 95% CI 2.5-16.4), agitation or confusion (OR = 6.0, 95% CI 2.6-13.7), hypertension (OR = 5.6, 95% CI 1.9-16.4) and tachypnoea/dyspnoea (OR = 2.8, 95% CI 1.2-6.1). After backwards stepwise logistic regression, the following were retained as significant independent predictors of mortality: acidosis (OR = 5.4, 95% CI: 1.8 - 16.5), tachycardia (OR = 3.6, 95% CI: 1.2 - 11.0), agitation/confusion (OR = 3.4, 95% CI: 1.2 - 9.7) and hyperpyrexia (OR = 2.8, 95% CI: 1.0 - 7.4).
DISCUSSION: DNP toxicity is uncommonly reported to poisons centres but has recently become more frequent in the United States and United Kingdom. Tachycardia, hyperpyrexia, acidosis, and agitation/confusion are independent risk factors for mortality and their presence should prompt rapid escalation to an intensive care environment for aggressive supportive treatment and monitoring.
参考来源
- Potts AJ, Bowman NJ, Seger DL, et al. Toxicoepidemiology and predictors of death in 2,4-dinitrophenol (DNP) toxicity. Clin Toxicol (Phila). 2020. PMID: 33021407. doi:10.1080/15563650.2020.1826505
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。